Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew J. Yee, M.D.

Co-Author

This page shows the publications co-authored by Andrew Yee and Elizabeth O'Donnell.
Connection Strength

0.680
  1. A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma. Br J Haematol. 2018 07; 182(2):222-230.
    View in: PubMed
    Score: 0.195
  2. Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma. EBioMedicine. 2015 Jan; 2(1):71-3.
    View in: PubMed
    Score: 0.154
  3. Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia. Leukemia. 2021 Sep 16.
    View in: PubMed
    Score: 0.062
  4. Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states. Skeletal Radiol. 2019 May; 48(5):773-779.
    View in: PubMed
    Score: 0.050
  5. Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia. J Clin Oncol. 2018 09 20; 36(27):2755-2761.
    View in: PubMed
    Score: 0.050
  6. Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing. Leukemia. 2018 08; 32(8):1838-1841.
    View in: PubMed
    Score: 0.048
  7. Abdominal adipose tissue in MGUS and multiple myeloma. Skeletal Radiol. 2016 Sep; 45(9):1277-83.
    View in: PubMed
    Score: 0.043
  8. Role of decorin in multiple myeloma (MM) bone marrow microenvironment. J Bone Miner Res. 2015 Mar; 30(3):465-70.
    View in: PubMed
    Score: 0.039
  9. Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death. Br J Haematol. 2015 May; 169(3):423-34.
    View in: PubMed
    Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.